Stock BuybacksBy The Online Investor Staff, updated Mon., Jan. 24, 12:18 PM
|This Slide: #19 of 25|
Slide #19. West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. (NYSE:WST)
Share Amount Authorized:
West Pharmaceutical Services, Inc.(NYSE:WST), a global leader in innovative solutions for injectable drug administration, today announced that the Company's Board of Directors have approved a first-quarter 2022 dividend of$0.18per share. The dividend will be paid onFebruary 2, 2022, to shareholders of record as ofJanuary 19, 2022. The Company's Board of Directors authorized a share repurchase program for calendar-year 2022 of up to 650,000 shares of the Company's common stock from time to time on the open market or in privately negotiated transactions, as permitted under Exchange Act Rule 10b-18. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions. The share repurchase program is expected to be completed by December 31, 2022. The Company's previously authorized share repurchase program expired on December 31, 2021.
West Pharmaceutical Services is a manufacturer in the design and production of containment and delivery systems for injectable drugs and healthcare products. Co.'s products include packaging, containment solutions, reconstitution and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services and integrated solutions. Co.'s segments are: Proprietary Products, which provides packaging, containment and drug delivery products, analytical lab services and integrated solutions; and Contract-Manufactured Products, which is focused on the design, manufacture, and automated assembly of devices, for pharmaceutical, diagnostic, and medical device customers.
WST SEC Filing Email Alerts Service
Open the WST Page at The Online Investor »
Free WST Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts
Buy (3.20 out of 4)